Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus

Citation
S. Narumi et al., Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus, CYTOKINE, 12(10), 2000, pp. 1561-1565
Citations number
15
Categorie Soggetti
Cell & Developmental Biology
Journal title
CYTOKINE
ISSN journal
10434666 → ACNP
Volume
12
Issue
10
Year of publication
2000
Pages
1561 - 1565
Database
ISI
SICI code
1043-4666(200010)12:10<1561:SLOIPR>2.0.ZU;2-T
Abstract
IFN-inducible protein-10 (IP-10) is supposed to act as a specific chemoattr actant for Th-1 cells. Since Th-1 cells and IFN-gamma are shown to be impor tant for developing systemic lupus erythematosus (SLE), we examined the rel ationship between serum IP-10 levels and the disease activity. Serum IP-IO levels were markedly increased in the SLE patients depending on the level o f disease activity, whereas not in the patients with rheumatoid arthritis ( RA), On the other hand, serum MCP-I levels were increased to a similar exte nt both in RA and inactive SLE patients, and a little more elevated in acti ve SLE patients. Serum IP-10 levels in SLE patients correlated positively a nd negatively with levels of anti-DNA antibody and complements, respectivel y, whereas MCP-1 levels correlated less or not at all, These results sugges t that serum IP-10 levels could be a good indicator for the activity of SLE and that IP-10 could play an important immunological role in SLE. (C) 2000 Academic Press.